Log In
Print
BCIQ
Print
Print this Print this
 

Bionect, 0.2% hyaluronic acid

  Manage Alerts
Collapse Summary General Information
Company Innocutis Holdings LLC
DescriptionLow moleuclar weight formulation of hyaluronic acid
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentMarketed
Standard IndicationDermatosis
Indication DetailsTreat skin irritation associated with radiation and chemotherapy
Regulatory Designation

Partner

Dara BioSciences Inc.; Mission Pharmacal Co.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today